Carnosine
Also known as: Beta-Alanyl-L-Histidine, L-Carnosine
Carnosine is a naturally occurring dipeptide composed of beta-alanine and histidine that functions as a potent antioxidant and anti-glycation agent. This endogenous compound declines with age and plays crucial roles in muscle function, neuroprotection, and cellular longevity.
Carnosine is a 226.23 g/mol research peptide. Carnosine is a naturally occurring dipeptide composed of beta-alanine and histidine that functions as a potent antioxidant and anti-glycation agent. This endogenous compound declines with age and plays crucial roles in muscle function, neuroprotection, and cellular longevity.
Also called: Beta-Alanyl-L-Histidine, L-Carnosine
226.23 g/mol
Molecular Weight
Daltons
2
Strong Evidence
benefits
5
Studies Cited
peer-reviewed
500-1500
Typical Dose
mg
Overview
Carnosine represents one of the most studied anti-aging compounds in peptide research, functioning through multiple protective mechanisms including advanced glycation end-product (AGE) inhibition, metal ion chelation, and free radical scavenging. The dipeptide exists naturally in skeletal muscle, cardiac tissue, and the nervous system, where concentrations decrease significantly with aging. Research demonstrates carnosine's ability to extend cellular lifespan in vitro, protect against oxidative stress, and maintain muscle function during aging. Its unique capacity to neutralize reactive carbonyl species and prevent protein cross-linking makes it particularly valuable for longevity research. Unlike many peptides, carnosine can be administered orally with reasonable bioavailability, though injection protocols offer superior tissue targeting. The compound's safety profile spans decades of research, with minimal adverse effects reported even at high doses.
Key Takeaways: Carnosine
- Strongest evidence supports Carnosine for advanced glycation end-product inhibition and muscle function and endurance
- Research doses typically range from 500 to 1500 mg via oral
- 2 benefits with strong evidence, 3 moderate, 2 preliminary
- Half-life: 2-3 hours in plasma
- 5 cited research studies in this guide
Mechanism of Action
Carnosine exerts its effects through multiple pathways including inhibition of advanced glycation end-product formation, metal ion chelation (particularly copper and zinc), free radical scavenging, and pH buffering in muscle tissue. The compound directly binds to reactive carbonyl species, preventing protein and DNA cross-linking that contributes to cellular aging. Additionally, carnosine modulates enzyme activity including carnosinase, which degrades the peptide itself, creating a regulatory feedback loop that influences tissue concentrations.
Research Benefits
Carnosine at a Glance
Carnosine exerts its effects through multiple pathways including inhibition of advanced glycation end-product formation, metal ion chelation (particularly copper and zinc), free radical scavenging, and pH buffering in muscle tissue.
Advanced Glycation End-Product Inhibition
Strong EvidenceCarnosine effectively prevents the formation of AGEs, which accelerate aging and contribute to diabetic complications. The peptide binds directly to reactive carbonyl compounds, blocking their interaction with proteins and DNA.
Muscle Function and Endurance
Strong EvidenceActs as a pH buffer in skeletal muscle, reducing lactic acid accumulation during intense exercise. Research shows improved muscle contraction efficiency and reduced fatigue in carnosine-supplemented subjects.
Neuroprotection and Cognitive Function
Moderate EvidenceProtects neurons from oxidative damage and protein aggregation associated with neurodegenerative diseases. Studies demonstrate improved cognitive function and reduced neuroinflammation in animal models.
Cellular Longevity and Senescence Delay
Moderate EvidenceExtends cellular lifespan in cultured human fibroblasts by up to 20% and delays senescence markers. The anti-glycation properties help maintain cellular structure and function during aging.
Cardiovascular Protection
Moderate EvidenceReduces formation of atherosclerotic plaques and protects against ischemia-reperfusion injury through antioxidant mechanisms. Clinical studies show improved endothelial function in diabetic patients.
Wound Healing Enhancement
PreliminaryAccelerates tissue repair through improved collagen synthesis and reduced inflammatory response. Topical applications demonstrate faster healing rates and reduced scarring in research models.
Anti-Inflammatory Effects
PreliminaryModulates inflammatory cytokine production and reduces markers of systemic inflammation. Research indicates potential benefits for chronic inflammatory conditions and autoimmune disorders.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| General anti-aging research | 500–1500 mg | oral |
| Athletic performance studies | 800–2000 mg | oral |
| Neuroprotection research | 100–500 mg | subcutaneous |
| Cardiovascular protection studies | 1000–3000 mg | oral |
Frequency
Once to twice daily
Timing
With meals to improve absorption and reduce gastric irritation
Cycle Length
Continuous use in most research protocols, with periodic assessment
Research Notes
- 1Oral bioavailability is limited by carnosinase enzyme activity
- 2Injectable forms bypass first-pass metabolism for higher tissue concentrations
- 3Higher doses may cause mild gastrointestinal upset initially
- 4Research suggests benefits accumulate with consistent long-term use
Reconstitution Guide
Standard Reconstitution
Vial Size
100 mg
Bacteriostatic Water
2 mL
Concentration
500 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Carnosine vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 2 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C refrigerated. 30 days refrigerated once reconstituted.
Storage Temperature
2-8°C refrigerated
Shelf Life
30 days refrigerated once reconstituted
Important Notes
- •Use bacteriostatic water for multi-dose vials
- •Powder form is stable at room temperature for extended periods
- •Avoid shaking vigorously to prevent peptide degradation
- •Reconstituted solution should be clear and colorless
Carnosine Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Carnosine Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Mild gastrointestinal upset at higher oral doses
- !Temporary metallic taste sensation
- !Transient hyperactivity or insomnia in sensitive individuals
- !Potential histamine-like reactions in rare cases
- !Injection site irritation with subcutaneous administration
- !Possible interaction with zinc absorption at very high doses
- !Rare reports of skin flushing or tingling sensations
- !Potential alteration of copper metabolism with chronic high-dose use
Potential Interactions
- ⚡May enhance absorption and effects of other antioxidants like vitamin C and E
- ⚡Potential interaction with zinc supplements, possibly reducing absorption
- ⚡Could theoretically enhance effects of other anti-glycation compounds
- ⚡May interact with medications metabolized by carnosinase enzyme
- ⚡Possible additive effects with other pH-buffering supplements in athletes
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro
Demonstrated carnosine's ability to prevent LDL glycation and foam cell formation, key processes in atherosclerosis development.
The effect of carnosine on cellular senescence of cultured human fibroblasts
Showed that carnosine treatment extended cellular lifespan and delayed senescence markers in human fibroblast cultures by approximately 20%.
Carnosine supplementation and muscle power output in athletes
Clinical trial demonstrating improved muscle power output and reduced fatigue in athletes supplementing with carnosine precursors.
Neuroprotective effects of carnosine in Alzheimer's disease model
Animal study showing carnosine reduced amyloid plaque formation and improved cognitive function in transgenic Alzheimer's disease mice.
Anti-glycation properties of carnosine and related compounds
Comprehensive review of carnosine's anti-glycation mechanisms and potential therapeutic applications in age-related diseases.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Carnosine is the active dipeptide that provides direct antioxidant and anti-glycation benefits, while beta-alanine is a precursor that increases muscle carnosine levels over time. Direct carnosine supplementation provides immediate systemic effects, whereas beta-alanine specifically targets muscle tissue carnosine synthesis.
Acute effects like improved exercise performance may be noticed within days, while anti-aging and neuroprotective benefits typically require weeks to months of consistent use. Research suggests optimal tissue saturation occurs after 4-6 weeks of regular supplementation.
Yes, carnosine often works synergistically with other antioxidants like vitamin C, vitamin E, and glutathione. Many research protocols combine carnosine with complementary compounds for enhanced protective effects.
Injectable carnosine bypasses the carnosinase enzyme in the digestive system, achieving higher and more sustained blood levels. While oral forms are convenient and effective, injection provides superior bioavailability for research applications.
Carnosine is unique in its dual role as both an antioxidant and anti-glycation agent. Unlike many synthetic peptides, it occurs naturally in human tissue and has extensive safety data from decades of research.
Research shows carnosine may help prevent diabetic complications by inhibiting advanced glycation end-product formation, which damages blood vessels and organs in diabetes. However, it should complement, not replace, standard diabetic care.
Carnosine has relatively few drug interactions, but it may enhance the effects of other antioxidants and could theoretically interact with zinc-dependent medications. Always consult healthcare providers before combining with prescription drugs.
Research protocols typically use 500-1500mg daily for general anti-aging benefits, with higher doses up to 3000mg studied for specific conditions. The optimal dose varies based on individual factors and specific research objectives.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.